Rafael L. Bras

Brain Scientific Signs Agreement with MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space

Retrieved on: 
Thursday, December 15, 2022
Pediatrics, IOM, Neurology, D. Medical Industries, D, Failure, Government, FDA, Brain, Rafael L. Bras, EMG, OEM, Intensive care unit, Sleep, Public expenditure, Projection, EEG, OTCQB, Research, Child, Patient, Medical device, Medical imaging, Fulcrum

LAKEWOOD RANCH, Fla., Dec. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific ( OTCQB:BRSF ), a Florida-based applied science technology company, announces today a new distribution agreement with MVAP Medical Supplies to drive sales into the rapidly growing and underserved pediatric EEG marketplace.

Key Points: 
  • LAKEWOOD RANCH, Fla., Dec. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific ( OTCQB:BRSF ), a Florida-based applied science technology company, announces today a new distribution agreement with MVAP Medical Supplies to drive sales into the rapidly growing and underserved pediatric EEG marketplace.
  • “For pediatric EEGs, Brain Scientific’s innovative NeuroCapTM – which shortens EEG setup times and provides staff and patients with more ease of use and comfort – is a perfect fit,” said Eric Jensen, CEO of MVAP Medical Supplies.
  • It has critical applications in pediatrics, emergency and ICUs, at-home care and research,” said Hassan Kotob, CEO of Brain Scientific.
  • Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices.

Neurovative Diagnostics Announces Partnership with NeuroX

Retrieved on: 
Tuesday, October 25, 2022
Physician, Rafael L. Bras, CSO, Growth, Stroke, Multiple sclerosis, Neuroscience, Patient, Parkinson's disease, EEG, Entrepreneurship, Long-term video-EEG monitoring, Partnership, Technology, Neurology, Medical director, Industry, MD, Continuous monitoring, Continuity, CEO, Health, Neuro, Movement disorders, Medical imaging, Medical device, NeuroDiagnostic Institute, Neurovation Labs

ORLANDO, Fla., Oct. 25, 2022 /PRNewswire/ -- Neurovative Diagnostics, a best-in-class industry leader providing in-home EEG testing and Continuous Monitoring services in acute care settings, announced a partnership with NeuroX, a physician-led, global telemedicine company and leading online clinic for neuro-psychology and neuroscience.

Key Points: 
  • ORLANDO, Fla., Oct. 25, 2022 /PRNewswire/ -- Neurovative Diagnostics, a best-in-class industry leader providing in-home EEG testing and Continuous Monitoring services in acute care settings, announced a partnership with NeuroX, a physician-led, global telemedicine company and leading online clinic for neuro-psychology and neuroscience.
  • Dr. Umar Farooq, NeuroX's Medical Director, notes, "Our partnership with Neurovative is another step towards providing high quality and convenient neurological care and remote patient monitoring to our patients.
  • Our partnership with NeuroX is a great example of our evolving healthcare delivery system working towards being more patient-centric."
  • NeuroX, a project of American TelePhysicians Inc., is thrilled to partner with Neurovative Diagnostics, a world-class EEG company, for its Neurology ecosystem in delivering affordable, convenient, and prompt online brain healthcare services at patients' doorsteps".

Zeto and Next Gen Neuro Partner for Remote EEG Monitoring

Retrieved on: 
Monday, August 29, 2022
Rafael L. Bras, Partnership, CA, CEO, NGN, Sleep, Concussion, Autism, EEG, Reading, Goal, Hospital, GLOBE, Stroke, FDA, Interview, Electroencephalography, Epilepsy, Patient, Medical imaging, Health insurance, NeuroDiagnostic Institute, NeuroDiagnostic Institute, Zeto

SANTA CLARA, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , a medical technology company, has announced its partnership with Next Gen Neuro , a continuous and routine EEG monitoring company, to provide remote EEG monitoring services.

Key Points: 
  • SANTA CLARA, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , a medical technology company, has announced its partnership with Next Gen Neuro , a continuous and routine EEG monitoring company, to provide remote EEG monitoring services.
  • Next Gen Neuro (NGN) will serve Zeto customers with real-time EEG monitoring within 30 minutes of a request via the Zeto software.
  • Their registered EEG technologists (R.EEG.T) would then remotely view the EEG and patient video and make annotations.
  • To learn more about Zeto's products including the remote EEG monitoring, please visit: https://zeto-inc.com or email us at [email protected] .

Zeto Introduces a Remote EEG Reading Service to Its Customers

Retrieved on: 
Thursday, May 26, 2022
Electroencephalography, Health, Stroke, Epilepsy, Adult, Autism, Sleep, FDA, Partnership, EEG, Zeto, Concussion, Hospital, Rafael L. Bras, CA, District, GLOBE, Medicine, Medical imaging

SANTA CLARA, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , announced today that the company is now offering its customers a remote electroencephalography (EEG) reading service.

Key Points: 
  • SANTA CLARA, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , announced today that the company is now offering its customers a remote electroencephalography (EEG) reading service.
  • "Telehealth-driven technologies, such as Zeto's EEG cloud platform , are great modern tools that allow EEGs to be interpreted quickly and seamlessly.
  • We are pleased to offer this service to our customers," said Florian Strelzyk, Chief Sales Officer at Zeto.
  • To learn more about Zeto's products including the reading service, please visit: www.zetoinc.com or email us at [email protected]

Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Retrieved on: 
Tuesday, May 10, 2022
Epilepsy, Brain, Twitter, Algorithm, Stratus, Data collection, Patient, Doctor of Philosophy, Partnership, Clinical trial, Beacon, Sleep, Machine learning, Neurology, Adoption, EEG, LinkedIn, View, Lists of diseases, Head, Solution, Technology, Rafael L. Bras, Neurodegeneration, Biosignal, Acquisition, Multimedia, Medical device, Medical imaging, Alzheimer's disease, MD

BOSTON, May 10, 2022 /PRNewswire/ -- Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation's leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon's machine learning neuroanalytics platform.

Key Points: 
  • By linking their platforms, Beacon and Stratus will unlock AI-powered at-home clinical trials, addressing these challenges head-on.
  • Stratus is proud to partner with Beacon and its ability to complete the equation by providing algorithms to ensure the quality of EEG interpretations."
  • "Reliable and replicable quantitative endpoints help drive faster, better-powered trials," said Jacob Donoghue, MD, PhD, co-founder of Beacon Biosignals.
  • Through novel machine learning algorithms, large clinical datasets, and advances in software engineering, Beacon Biosignals empowers biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data.

Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

Retrieved on: 
Wednesday, February 16, 2022
Biotechnology, Medical Devices, Hardware, Health, Technology, Colorado EKG Repository, ICU, Patient, Seizure, Epilepsy, Venture, CEO, Â, Neurology, EEG, Brain, REMI, Rafael L. Bras, CHV, Review, Ward, Epilepsy Foundation, Medtech, Geography, Biology, Doctor of Philosophy, Director, FDA, Population, View, Board, Innovation, NIH, Heart, Principal, Multimedia, Diagnosis, OSF, Investment, Independent director, Life, OSF HealthCare, Medical device, Bank, Medical imaging, Dexcom, Transformation/transcription domain-associated protein

Epitel, Inc. , a digital health company developing a wearable, wireless EEG monitoring platform for seizure detection, announced today the closing of a $12.5 million Series A financing for initial pilot commercialization and further development of its proprietary platform.

Key Points: 
  • Epitel, Inc. , a digital health company developing a wearable, wireless EEG monitoring platform for seizure detection, announced today the closing of a $12.5 million Series A financing for initial pilot commercialization and further development of its proprietary platform.
  • View the full release here: https://www.businesswire.com/news/home/20220216005643/en/
    Epitel introduces REMI, a wearable, wireless EEG monitoring platform for seizure detection.
  • Because the Epitel System is wearable and wireless, it can continue to monitor the patient continuously for 48 hours during their hospital journey.
  • Epitel is a digital health company developing a wearable, wireless EEG monitoring platform to provide accessible, affordable, and reliable for seizure detection.

Brain Scientific Issues Shareholder Letter and Corporate Update

Retrieved on: 
Monday, January 31, 2022
Diagnosis, Public expenditure, Neurology, Cell, Alloy, Technology, Medtech, Efficiency, Medicare, Research, MRI, Prevalence, Electrode, GLOBE, Telehealth, Time, Cardiology, Pump, DC, CEO, Epilepsy, Kaiser Family Foundation, MICROSCOPE, Original equipment manufacturer, Centers for Medicare & Medicaid Services, EEG, United States Department of Veterans Affairs, Population, Laboratory, CDC, Department, Smartphone, Motion, Hospital, Income, Government, Failure, OEM, Projection, Field line, Center, OTCQB, Life, Rafael L. Bras, Industry, FDA, Solution, Forward-looking statement, Patient, Intellectual property, Brain, Ideation, Dementia, ER, SEC, Head Injuries, Death, Seizure, Freedom, Ceramic, Hair, Biopsy, Movement, Nursing, Management, Medical device, Medical imaging, Electric motor, Electronic component, 3D printing

NEW YORK, Jan. 31, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a leader in the medical technology market, today issues the following letter to shareholders from Chairman and Chief Executive Officer Hassan Kotob.

Key Points: 
  • NEW YORK, Jan. 31, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a leader in the medical technology market, today issues the following letter to shareholders from Chairman and Chief Executive Officer Hassan Kotob.
  • On Oct. 1, 2021, Brain Scientific and Piezo Motion completed their merger and appointed me chairman and CEO of the combined entity.
  • Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices.
  • To learn more about Brain Scientific's corporate strategy, products or investor relations, please visit brainscientific.com .

Kerna Health Signs Deal with Total Brain; Will Integrate Total Brain Platform into Existing Behavioral Health Technologies

Retrieved on: 
Thursday, January 13, 2022
Brain damage, Patient, Technology, Accountable care organization, Cognition, SAN, LinkedIn, Rafael L. Bras, Mental health, Growth, ASX, Health, Magnetic resonance imaging, TTB, Fatigue, Diabetes, Software as a service, Conditional sentence, Brain, Self-control, Risk, Twitter, STEN, Hospital, Partnership, Mobile phone, Medical imaging, Facebook

As part of the newly minted agreement, Kerna will integrate the Total Brain digital neurotech platform into the company's Behavioral Health Integration support solution.

Key Points: 
  • As part of the newly minted agreement, Kerna will integrate the Total Brain digital neurotech platform into the company's Behavioral Health Integration support solution.
  • The Total Brain platform will extend the value of Kerna's existing virtual behavioral health solutions.
  • Clinicians incorporating Total Brain into their practice treat various conditions including substance use disorder, behavioral health disorders, traumatic brain injuries, mild cognitive impairment and more.
  • About Total Brain Limited (ASX: TTB)
    Total Brain Limited is a San Francisco and Sydney-based company that has developed and offers Total Brain, a mental health and brain performance self-monitoring and self-care platform powered by the world's largest standardized brain database.

Total Brain Extends Presence in the Behavioral Health and Addiction Treatment Markets

Retrieved on: 
Tuesday, December 28, 2021
Rafael L. Bras, Brain damage, Substance abuse, Health, Fatigue, Cognitive behavioral therapy, Multimedia, SAN, ASX, TTB, Health information management, Resonance, Self-control, Depression, Growth, Industry, Brain, Grief, Family, Mental health, Interview, Magnetic resonance imaging, PTSD, Cognition, Anxiety, EHR, Traction, Cape Cod, Meditation, Total, Patient, STEN, CEO, Pharmaceutical industry, Medical imaging, Medicine, MD

SAN FRANCISCO, Dec. 28, 2021 /PRNewswire/ --Total Brain, a mental health monitoring and support platform, extends its presence in the behavioral health and addiction treatment markets.

Key Points: 
  • SAN FRANCISCO, Dec. 28, 2021 /PRNewswire/ --Total Brain, a mental health monitoring and support platform, extends its presence in the behavioral health and addiction treatment markets.
  • The new and improved Total Brain clinical platform includes a clinically-validated assessment, mobile app-based self-care tools, and a clinician dashboard.
  • Clinicians incorporating Total Brain into their practice treat various conditions including substance use disorder, behavioral health disorders, traumatic brain injuries, mild cognitive impairment and more.
  • To learn more about how Dr. Norenberg integrates Total Brain into his clinical practice, listen to his interview with Dr. Gordon on the Total Brain podcast .

Total Brain Brings New Clinical Platform to the Behavioral Health and Addiction Treatment Markets; Offers Game-Changing Stress Management Tools

Retrieved on: 
Thursday, October 21, 2021
Technology, SAN, Brain damage, Self-control, Patient, Resonance, TTB, Cognitive behavioral therapy, Brain, Rafael L. Bras, Fatigue, Mental health, Cognition, CEO, Magnetic resonance imaging, EHR, ASX, Documentation, Health information management, STEN, HRV, Health, Crave, Meditation, Medical imaging

SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ --Total Brain, a mental health and brain performance self-monitoring and self-care platform, has launched a new and improved clinical platform for the behavioral health and addiction treatment markets.

Key Points: 
  • SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ --Total Brain, a mental health and brain performance self-monitoring and self-care platform, has launched a new and improved clinical platform for the behavioral health and addiction treatment markets.
  • The Total Brain clinical platform includes a clinically-validated assessment, mobile app-based self-care tools, and a clinician dashboard.
  • The new Total Brain clinical platform is in response to clinicians asking for a robust set of actionable data.
  • Total Brain is a mental health and brain performance self-monitoring and self-care platform that has more than 1M registered users.